Susan D Roseff, MD
Professor of Pathology
Chair of the Division of Clinical Pathology
Medical Director of Apheresis
Associate Director of the Resident Training Program
Office: (804) 828-0255
Fax: (804) 828-6156
Susan Roseff, MD, has been the Chair of the Division of Clinical Pathology, in the Department of Pathology at the Virginia Commonwealth University Health System, and Director of Apheresis, since July 2012. Prior to this appointment, she was the Medical Director of Transfusion Medicine at the VCU Health System beginning in 2000. She is also a member of the Board of Directors of the Virginia Commonwealth University Health System Authority, where she serves as the Board’s Secretary and as a member of the Executive Committee. Prior to joining VCU/VCUHS, Dr. Roseff worked for the American Red Cross Biomedical Services, beginning in 1993, serving as the Medical Director or Chief Medical Officer in regional blood services in Nashville, Tennessee, Charlotte, North Carolina and Columbia, South Carolina.
Dr. Roseff received her undergraduate degree at Brown University and attended medical school at Albany Medical College. After completing an internship in pediatrics at Duke University Medical Center, she trained in Clinical Pathology at George Washington University Medical Center. Dr. Roseff completed her Transfusion Medicine Fellowship at Vanderbilt University Medical Center and the American Red Cross.
Dr. Roseff’s major interests in Transfusion Medicine are pediatric/neonatal transfusion medicine, as well as blood management. She is also interested in the treatment of patients with sickle cell disease and has been a co-investigator on 2 federally funded sickle cell research projects. As the Chair of the Division of Clinical Pathology, she has become involved in projects looking at sample volume, lab utilization and reference test utilization.
Dr. Roseff has a passion for education and has an active role in the Department, Medical Center, School of Medicine, and as an invited lecturer/course director at both regional and national meetings. She had leadership roles in the Department’s Pathology Resident Training Program and in the school of medicine, as a co-course director in the second year hematology/oncology course. Dr. Roseff has also served a role in implementing the new medical school curriculum and is a Course Master for the “Marrow and Movement” block of the new school of medicine curriculum. In 2006 Dr. Roseff was awarded with the Department of Pathology’s Saul Kay Award. This award is presented by the graduating residents to a faculty member who is uniquely dedicated and effective in resident teaching. In October 2014 she was awarded the Enrique Gerszten Faculty Teaching Excellence Award, the VCU School of Medicine’s highest teaching award.
Dr. Roseff has served in leadership positions in a variety of national and international professional organizations and is currently a member of the AABB’s Board of Directors. She has previously served as the Chair of the AABB’s Standards Program Unit and also serves as AABB’s liaison to the Department of Health and Human Services Advisory Committee on Blood and Tissue Safety and Availability. In addition, she was a member of the College of American Pathologist’s Transfusion Medicine Resource Committee from 2006 – 2011. She also served as a member of the Department of Health and Human Services’ Advisory Committee on Blood Safety and Availability from 2005-2008. In September 2012 Dr. Roseff was invited to be a temporary voting member of the Blood Products Advisory Committee to the FDA for the topics “Octapharm” and “Point of Issue Testing of Platelet Components for Bacterial Contamination.” She has also served as a committee chairs for ASFA (American Society for Apheresis) and the ASCP (American Society of Clinical Pathology). Dr. Roseff is Board Certified in Clinical Pathology and Transfusion Medicine and Blood Banking by the American Board of Pathology.
Clinical Specialties: Pediatric Transfusion Therapy, Clinical Apheresis, Blood Component Therapy, Immunohematology, Sickle Cell Disease, Patient Blood Management and Laboratory Test Utilization